Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 20:41:100404.
doi: 10.1016/j.jcte.2025.100404. eCollection 2025 Sep.

Predicting accelerated fetal growth in pregnancy: beyond maternal hyperglycemia - The role of prothymosin-α, inflammatory cytokines, and angiogenic factors

Affiliations

Predicting accelerated fetal growth in pregnancy: beyond maternal hyperglycemia - The role of prothymosin-α, inflammatory cytokines, and angiogenic factors

Maria Mirabelli et al. J Clin Transl Endocrinol. .

Abstract

Aim: This study investigates prothymosin-α (ProT-α), an immunomodulatory protein, as a potential biomarker for insulin resistance in gestational diabetes (GDM), and as a predictor of fetal growth by 20 weeks of gestation (wg). Methods: Forty-six women with singleton pregnancies were classified into GDM (n = 8) and normal glucose tolerance (NGT; n = 38) groups based on 75 g OGTT results. Maternal glucose, insulin, cytokines, and ProT-α levels were measured, and fetal growth was assessed by ultrasound at 20 wg, focusing on abdominal circumference (AC) and estimated fetal weight (EFW) percentiles. Results: Women with GDM were older, had a higher BMI, glucose, and insulin levels, with fetuses showing higher AC and EFW percentiles. IL-8, TNFα, and IL-1α were lower in the GDM group, while ProT-α was also lower but not significantly. ProT-α inversely correlated with EFW percentiles, independent of GDM. Regression analysis identified 2-hour post-load glucose, VEGF, and EGF as positive predictors of fetal growth acceleration, while IL-10 and ProT-α were negative predictors. Conclusions: Fetal growth is influenced by maternal glucose, inflammation, and angiogenesis. ProT-α may serve as an independent biomarker for predicting fetal growth in early pregnancy, suggesting further investigation into its role in GDM, obesity, and insulin resistance.

Keywords: Cytokines; Fetal growth; Insulin resistance; Pregnancy; Prothymosin-α.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

None
Graphical abstract
Fig. 1
Fig. 1
Spearman’s correlation analysis between fetal growth parameters, abdominal circumference (AC), and estimated fetal weight (EFW) percentiles, measured at the mid-trimester ultrasound screening (20 wg) and at a follow-up scan performed later into gestation, shortly before the OGTT at 24 wg. The intensity of the color reflects the absolute magnitude of the correlation coefficient (r). Statistically significant correlations are marked with asterisks: * p < 0.05; ** p < 0.01; *** p < 0.001. Corresponding scatter plots of the correlations between AC and EFW percentiles at the two timepoints are also included.
Fig. 2
Fig. 2
Spearman’s correlation analysis between circulating ProT-α, inflammatory cytokines, and angiogenic factors. The blue shades represent positive correlations, the red shades indicate negative correlations, and the white color denotes no correlation. Statistically significant correlations are marked with asterisks: * p < 0.05; ** p < 0.01.

Similar articles

References

    1. Hartling L., Dryden D.M., Guthrie A., Muise M., Vandermeer B., Donovan L. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann. Intern. Med. 2013;159:123–129. - PubMed
    1. Ye W., Luo C., Huang J., Li C., Liu Z., Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022;377 - PMC - PubMed
    1. Chiefari E., Arcidiacono B., Foti D., Brunetti A. Gestational diabetes mellitus: an updated overview. J. Endocrinol. Invest. 2017;40:899–909. - PubMed
    1. Mirabelli M., Chiefari E., Tocci V., Greco E., Foti D., Brunetti A. Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options. Curr. Opin. Pharmacol. 2021;60:1–10. - PubMed
    1. Desoye G., Nolan C.J. The fetal glucose steal: an underappreciated phenomenon in diabetic pregnancy. Diabetologia. 2016;59:1089–1094. - PMC - PubMed

LinkOut - more resources